{"pmid":32418675,"title":"Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic.","text":["Radiotherapy and Systemic Treatment for Non-melanoma Skin Cancer in the COVID-19 Pandemic.","Clin Oncol (R Coll Radiol)","Rembielak, A","Sykes, A J","Fife, K","Challapalli, A","Nobes, J P","32418675"],"journal":"Clin Oncol (R Coll Radiol)","authors":["Rembielak, A","Sykes, A J","Fife, K","Challapalli, A","Nobes, J P"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32418675","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.clon.2020.04.014","topics":["Prevention"],"weight":1,"_version_":1667159284438269952,"score":9.490897,"similar":[{"pmid":32460421,"title":"Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post COVID-19 era: Time to reconsider its role for most patients.","text":["Hypofractionated radiotherapy in patients with non-melanoma skin cancer in the post COVID-19 era: Time to reconsider its role for most patients.","The most frequent cancer worldwide is skin cancer, occurring at epidemic rates in countries exposed to high levels of chronic ultraviolet radiation such as Australia and New Zealand (ANZ). Australia has the highest incidence of non-melanoma skin cancer (NMSC) in the world. NMSC is predominantly a cancer of the middle aged or elderly and accounts for considerable consulting and treatment time in most radiation oncology departments. Many patients also suffer from medical co-morbidity, an important factor in any treatment decision.","J Med Imaging Radiat Oncol","Veness, Michael","32460421"],"abstract":["The most frequent cancer worldwide is skin cancer, occurring at epidemic rates in countries exposed to high levels of chronic ultraviolet radiation such as Australia and New Zealand (ANZ). Australia has the highest incidence of non-melanoma skin cancer (NMSC) in the world. NMSC is predominantly a cancer of the middle aged or elderly and accounts for considerable consulting and treatment time in most radiation oncology departments. Many patients also suffer from medical co-morbidity, an important factor in any treatment decision."],"journal":"J Med Imaging Radiat Oncol","authors":["Veness, Michael"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32460421","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/1754-9485.13070","locations":["Australia","New Zealand","Australia"],"countries":["Australia","New Zealand"],"countries_codes":["AUS|Australia","NZL|New Zealand"],"topics":["Prevention"],"weight":1,"_version_":1667967699055017984,"score":77.24425},{"pmid":32426877,"title":"Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.","text":["Metastatic melanoma treatment with check point inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.","Melanoma epidemiology has shown a constant increase in the last few decades even if mortality is low and only a small percentage of patients develop metastatic disease. For these patients, immunotherapy with checkpoint inhibitors (ICI) significantly improves disease outcome with a median survival more than 2 years. The same drugs are used as adjuvant treatment in disease-free patients. Coronavirus Disease-19 (COVID-19) is now a pandemic disease with lung manifestations, which can bring severe acute respiratory distress. The most important risk factors related to a higher death risk for COVID-19 pneumonia are elderly age and comorbidities (hypertension, diabetes, previous cancer).","J Eur Acad Dermatol Venereol","Quaglino, Pietro","Fava, Paolo","Brizio, Matteo","Marra, Elena","Rubatto, Marco","Agostini, Andrea","Tonella, Luca","Ribero, Simone","Fierro, Maria Teresa","32426877"],"abstract":["Melanoma epidemiology has shown a constant increase in the last few decades even if mortality is low and only a small percentage of patients develop metastatic disease. For these patients, immunotherapy with checkpoint inhibitors (ICI) significantly improves disease outcome with a median survival more than 2 years. The same drugs are used as adjuvant treatment in disease-free patients. Coronavirus Disease-19 (COVID-19) is now a pandemic disease with lung manifestations, which can bring severe acute respiratory distress. The most important risk factors related to a higher death risk for COVID-19 pneumonia are elderly age and comorbidities (hypertension, diabetes, previous cancer)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Quaglino, Pietro","Fava, Paolo","Brizio, Matteo","Marra, Elena","Rubatto, Marco","Agostini, Andrea","Tonella, Luca","Ribero, Simone","Fierro, Maria Teresa"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426877","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jdv.16586","locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Treatment"],"weight":1,"_version_":1667252837773475841,"score":53.001484},{"pmid":32485048,"title":"Increasing melanoma awareness amongst health and social care professionals in secondary care in an era of reduced skin cancer referrals.","text":["Increasing melanoma awareness amongst health and social care professionals in secondary care in an era of reduced skin cancer referrals.","The Covid 19 outbreak has resulted in a reduction in cancer referrals. The Health Service Executive (HSE) in Ireland reports a reduction of 72% in pigmented lesion referrals since the pandemic began. This is concerning and likely reflects the fact that people are ignoring symptoms and delaying seeking medical advice due to fears related to Covid 19.","Clin Exp Dermatol","Quinlan, C","Gill, R","Murphy, M","32485048"],"abstract":["The Covid 19 outbreak has resulted in a reduction in cancer referrals. The Health Service Executive (HSE) in Ireland reports a reduction of 72% in pigmented lesion referrals since the pandemic began. This is concerning and likely reflects the fact that people are ignoring symptoms and delaying seeking medical advice due to fears related to Covid 19."],"journal":"Clin Exp Dermatol","authors":["Quinlan, C","Gill, R","Murphy, M"],"date":"2020-06-03T11:00:00Z","year":2020,"_id":"32485048","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1111/ced.14323","locations":["Ireland"],"countries":["Ireland"],"countries_codes":["IRL|Ireland"],"topics":["Prevention"],"weight":1,"_version_":1668532114719506432,"score":49.68737},{"pmid":32337386,"pmcid":"PMC7179507","title":"Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.","text":["Practice considerations for proton beam radiotherapy of uveal melanoma during the COVID-19 pandemic: PTCOG Ocular experience.","Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment.","Adv Radiat Oncol","Mishra, K K","Afshar, A","Thariat, J","Shih, H A","Scholey, J E","Daftari, I K","Kacperek, A","Pica, A","Hrbacek, J","Dendale, R","Mazal, A","Heufelder, J","Char, D H","Sauerwein, W","Weber, D C","Damato, B E","32337386"],"abstract":["Uveal melanoma (UM) is a rare but life-threatening cancer of the eye. In light of the COVID-19 pandemic, hospitals and proton eye therapy facilities must analyze several factors to ensure appropriate treatment protocols for patients and provider teams. Practice considerations to limit COVID-19 transmission in the proton ocular treatment setting for UM are necessary. The Particle Therapy Co-Operative Group (PTCOG) is the largest international community of particle/proton therapy providers. Participating experts are/were affiliated with the member institutions of the PTCOG Ocular subcommittee with long-standing high-volume proton ocular programs. The practices reviewed in this document must be taken in conjunction with local hospital procedures, multidisciplinary recommendations, and regional/national guidelines, as each community may have its unique needs, supplies, and protocols. Importantly, as the pandemic evolves, so will the strategies and recommendations. Given the unique circumstances for UM patients, along with indications of potential ophthalmologic transmission as a result of healthcare providers working in close proximity to patients and intrinsic infectious risk from eyelashes, tears and hair, practice strategies may be adapted to reduce the risk of viral transmission. Certainly, providers and health care systems will continue to examine and provide as safe and effective care as possible for patients in the current environment."],"journal":"Adv Radiat Oncol","authors":["Mishra, K K","Afshar, A","Thariat, J","Shih, H A","Scholey, J E","Daftari, I K","Kacperek, A","Pica, A","Hrbacek, J","Dendale, R","Mazal, A","Heufelder, J","Char, D H","Sauerwein, W","Weber, D C","Damato, B E"],"date":"2020-04-28T11:00:00Z","year":2020,"_id":"32337386","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.adro.2020.04.010","topics":["Prevention"],"weight":1,"_version_":1666138494301372417,"score":48.61305},{"pmid":32471016,"title":"Virtual melanoma checks during a pandemic.","text":["Virtual melanoma checks during a pandemic.","Healthcare services internationally are experiencing unprecedented strain due to the COVID-19 pandemic. Governments mandate strict social distancing to reduce the spread of SARS-CoV-2 infection, and as a result, people are avoiding health services for less urgent issues. In this crisis, it is important that patients continue to receive preventive and surveillance care without compromising their safety or that of healthcare workers.","Br J Dermatol","Janda, M","Swetter, S M","Horsham, C","Soyer, H P","32471016"],"abstract":["Healthcare services internationally are experiencing unprecedented strain due to the COVID-19 pandemic. Governments mandate strict social distancing to reduce the spread of SARS-CoV-2 infection, and as a result, people are avoiding health services for less urgent issues. In this crisis, it is important that patients continue to receive preventive and surveillance care without compromising their safety or that of healthcare workers."],"journal":"Br J Dermatol","authors":["Janda, M","Swetter, S M","Horsham, C","Soyer, H P"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32471016","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1111/bjd.19255","topics":["Prevention"],"weight":1,"_version_":1668420887165009920,"score":44.595036}]}